Mingozzi Federico

CIK 00017321261 companyPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001732126

Recent Transactions

16 trades

Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−35,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−18,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−50,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Restricted Stock Units
2019-12-17−32,750→ 0 total
Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−12,615→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-06-26+8,375→ 15,390 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2019-06-26−8,375→ 16,750 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-06-26$102.31/sh−2,775→ 12,615 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-01-18$45.08/sh−733→ 7,015 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-01-18+2,000→ 7,748 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2019-01-18−2,000→ 6,000 total
Award
Spark Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-01-15+35,000→ 35,000 total
Award
Spark Therapeutics, Inc.
Restricted Stock Units
2019-01-15+10,000→ 10,000 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2018-06-26−8,375→ 25,125 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2018-06-26+8,375→ 8,375 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2018-06-26$87.98/sh−2,627→ 5,748 total

Companies

Spark Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

3737 MARKET STREET SUITE 1300

PHILADELPHIA, PA, 19104

View on SEC.gov